Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Enhertu demonstrated clinically meaningful and durable response in patients with HER2-positive advanced gastric cancer in DESTINY-Gastric02 Phase II trial
-
Imfinzi combined with novel immunotherapies improved clinical outcomes for patients with unresectable, Stage III non-small cell lung cancer
-
Imfinzi and tremelimumab with chemotherapy improved progression-free survival by 28% and overall survival by 23% in 1st-line Stage IV non-small cell lung cancer vs. chemotherapy
-
International Respiratory Coalition launches to transform post-pandemic respiratory healthcare
-
Fixed-dose combination of albuterol and budesonide (PT027) demonstrated significant benefits for asthma patients in MANDALA and DENALI Phase III trials
-
AstraZeneca and European Commission reach settlement agreement over vaccine supply, ending litigation
-
Ultomiris approved in the EU for children and adolescents with paroxysmal nocturnal haemoglobinuria
-
AstraZeneca lung and breast cancer data at WCLC and ESMO 2021 underscore ambition to revolutionise outcomes for patients
-
Forxiga approved in Japan for the treatment of chronic kidney disease in patients with and without type-2 diabetes
-
ALXN1840 FoCus Phase III trial in Wilson disease met primary endpoint demonstrating improvement in copper mobilisation from tissues
Latest articles and press releases
All of our latest press releases and articles are available to explore
